ArticleScientific reports2025

Second-generation BRAF inhibitor Encorafenib resistance is regulated by NCOA4-mediated iron trafficking in the drug-resistant malignant melanoma cells.

Ceyda Colakoglu Bergel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.